Acarix AB Stock OTC Markets
Stocks
ACIXF
SE0009268717
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0218 USD | -16.31% |
|
-.--% | -28.52% |
| 06-17 | Acarix AB Announces Directorate Appointments | CI |
| 06-16 | Acarix AB Announces That Marlou Janssen-Counott Declines Re-Election as A Member of the Board of Directors | CI |
| Market Cap | 299M 31.38M 27.28M 25.39M 23.31M 44.02M 3B 44.7M 117M 1.49B 118M 115M 5B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 299M 31.38M 27.28M 25.39M 23.31M 44.02M 3B 44.7M 117M 1.49B 118M 115M 5B | EV / Sales 2026 * |
15.7x | EV / Sales 2027 * | 4.31x |
| Free-Float |
83.24% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Acarix AB
| 1 day | -16.31% | ||
| 1 month | -24.57% | ||
| 3 months | -27.09% | ||
| 6 months | -36.81% | ||
| Current year | -28.52% |
| 1 month | 0.02 | 0.03 | |
| Current year | 0.02 | 0.04 | |
| 1 year | 0.02 | 0.04 | |
| 3 years | 0.01 | 0.07 | |
| 5 years | 0.01 | 0.07 | |
| 10 years | 0.01 | 0.07 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aamir Mahmood
CEO | Chief Executive Officer | - | 2024-01-31 |
| Chief Executive Officer | 62 | 2018-02-22 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 2019-12-31 | |
Kenneth Nelson
BRD | Director/Board Member | 52 | 2024-05-13 |
Tony Das
BRD | Director/Board Member | - | 2024-05-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -16.31% | -.--% | - | - | 31.38M | ||
| -1.89% | -1.36% | +16.24% | -41.91% | 15.7B | ||
| +4.47% | +7.46% | +1.25% | +106.27% | 1.77B | ||
| +1.21% | +4.49% | -27.15% | -80.80% | 1.14B | ||
| -1.73% | +2.33% | -38.79% | +13.42% | 980M | ||
| +1.29% | +7.31% | -46.81% | -52.67% | 655M | ||
| +0.93% | +7.41% | -45.76% | -53.34% | 543M | ||
| +1.08% | +2.47% | +53.71% | -51.95% | 472M | ||
| -0.81% | +1.33% | -53.54% | -62.03% | 374M | ||
| -0.81% | +5.14% | -15.69% | -32.94% | 368M | ||
| Average | -1.26% | +2.54% | -17.39% | -28.44% | 2.45B | |
| Weighted average by Cap. | -0.97% | -0.19% | +6.00% | -30.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 19.1M 2M 1.74M 1.62M 1.49M 2.81M 191M 2.85M 7.5M 95.17M 7.52M 7.36M 319M | 69.5M 7.29M 6.33M 5.9M 5.41M 10.22M 696M 10.38M 27.28M 346M 27.37M 26.77M 1.16B |
| Net income | -28.9M -3.03M -2.63M -2.45M -2.25M -4.25M -289M -4.32M -11.34M -144M -11.38M -11.13M -483M | 2.4M 252K 219K 204K 187K 353K 24.02M 358K 942K 11.96M 945K 924K 40.1M |
| Net Debt | - | - |
Employees
8
Calendar
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACARIX Stock
- ACIXF Stock
Select your edition
All financial news and data tailored to specific country editions

















